Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.

STUDY QUESTION Can ovarian tissue cryopreservation (OTC) be performed after controlled ovarian hyperstimulation (COH)? SUMMARY ANSWER Unilateral oophorectomy after transvaginal oocyte retrieval is feasible on stimulated ovaries during one surgical step. WHAT IS KNOWN ALREADY In the fertility preservation (FP) field, the timeframe between patient referral and start of curative treatment is limited. Combining oocyte pick-up with ovarian tissue (OT) extraction has been reported to improve FP but COH applied before OT extraction is not currently recommended. STUDY DESIGN, SIZE, DURATION This retrospective cohort-controlled study involved 58 patients who underwent oocyte cryopreservation immediately followed by OTC between September 2009 and November 2021. The exclusion criteria were a delay between oocyte retrieval and OTC of >24 h (n = 5) and IVM of oocytes obtained ex vivo in the ovarian cortex (n = 2). This FP strategy was performed either after COH (stimulated group, n = 18) or after IVM (unstimulated group, n = 33). PARTICIPANTS/MATERIALS, SETTING, METHODS Oocyte retrieval followed by OT extraction on the same day was performed either without previous stimulation or after COH. Adverse effects of surgery and ovarian stimulation, mature oocyte yield and pathology findings of fresh OT were retrospectively analysed. Thawed OTs were analysed prospectively, for vascularization and apoptosis using immunohistochemistry, when patient consent was obtained. MAIN RESULTS AND THE ROLE OF CHANCE No surgical complication occurred after OTC surgery in either group. In particular, no severe bleeding was associated with COH. The number of mature oocytes obtained increased after COH (median = 8.5 (25% = 5.3-75% = 12.0)) compared to the unstimulated group (2.0 (1.0-5.3), P < 0.001). Neither ovarian follicle density nor cell integrity was affected by COH. Fresh OT analysis showed congestion in half of the stimulated OT which was higher than in the unstimulated OT (3.1%, P < 0.001). COH also increased haemorrhagic suffusion (COH + OTC: 66.7%; IVM + OTC: 18.8%, P = 0.002) and oedema (COH + OTC: 55.6%; IVM + OTC: 9.4%, P < 0.001). After thawing, the pathological findings were similar between both groups. No statistical difference in the number of blood vessels was observed between the groups. The oocyte apoptotic rate in thawed OT was not statistically different between the groups (ratio of positive cleaved caspase-3 staining oocytes/total number of oocytes equal to median 0.50 (0.33-0.85) and 0.45 (0.23-0.58) in unstimulated and stimulated groups respectively, P = 0.720). LIMITATIONS, REASONS FOR CAUTION The study reports FP from a small number of women following OTC. Follicle density and other pathology findings are an estimate only. WIDER IMPLICATIONS OF THE FINDINGS Unilateral oophorectomy can be successfully performed after COH with limited bleeding risk and an absence of impact on thawed OT. This approach could be proposed to post pubertal patients when the number of mature oocytes expected is low or when the risk of residual pathology is high. The reduction of surgical steps for cancer patients also has positive implications for introducing this approach into clinical practice. STUDY FUNDING/COMPETING INTEREST(S) This work was made possible through the support of the reproductive department of Antoine-Béclère Hospital and of the pathological department of Bicêtre Hospital (Assistance Publique Hôpitaux de Paris, France). The authors have no conflict of interest to disclose in this study. TRIAL REGISTRATION NUMBER N/A.

[1]  F. Brugnon,et al.  Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation , 2022, Human reproduction.

[2]  N. Frydman,et al.  Mouse model of radiation-induced premature ovarian insufficiency reveals compromised oocyte quality: implications for fertility preservation. , 2021, Reproductive biomedicine online.

[3]  M. Peigné,et al.  Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women? , 2021, Human reproduction.

[4]  A. Pellicer,et al.  Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. , 2021, Fertility and sterility.

[5]  N. Frydman,et al.  Live birth rate after use of cryopreserved oocytes or embryos at the time of cancer diagnosis in female survivors: a retrospective study of ten years of experience , 2021, Journal of Assisted Reproduction and Genetics.

[6]  A. Pellicer,et al.  Disease-inducing potential of two leukemic cell lines in a xenografting model , 2021, Journal of Assisted Reproduction and Genetics.

[7]  F. Lundberg,et al.  Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation , 2020, JAMA oncology.

[8]  C. Venetis,et al.  Is there an optimal number of oocytes retrieved at which live birth rates or cumulative live birth rates per aspiration are maximized after ART? A systematic review. , 2020, Reproductive biomedicine online.

[9]  F. Amant,et al.  ESHRE guideline: female fertility preservation† , 2020, Human reproduction open.

[10]  H. Tournaye,et al.  Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study. , 2020, Human reproduction.

[11]  P. Patrizio,et al.  Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue. , 2020, Fertility and sterility.

[12]  Xiaomin Zheng,et al.  Exogenous luteinizing hormone promotes ovarian survival and function during cryopreservation and transplantation. , 2020, Biochemical and biophysical research communications.

[13]  J. Cervera,et al.  Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model. , 2019, Human reproduction.

[14]  J. Remohi,et al.  Elective and Onco-fertility preservation: factors related to IVF outcomes , 2018, Human reproduction.

[15]  Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. , 2018, Fertility and sterility.

[16]  K. Oktay,et al.  Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update Summary. , 2018, Journal of oncology practice.

[17]  P. Monnier,et al.  Thirteen years’ experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments , 2018, Journal of Assisted Reproduction and Genetics.

[18]  E. Ernst,et al.  Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort , 2018, Journal of Assisted Reproduction and Genetics.

[19]  Z. Blumenfeld Ovarian tissue transplantation and leukemia. , 2018, Fertility and sterility.

[20]  F. Martínez Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. , 2017, Fertility and sterility.

[21]  K. Oktay,et al.  Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis , 2017, Reproductive Sciences.

[22]  Hao Wu,et al.  The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone , 2015, BioMed research international.

[23]  S. Elizur,et al.  Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield. , 2015, Reproductive biomedicine online.

[24]  J. Donnez,et al.  Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes , 2014, Journal of Ovarian Research.

[25]  Deo Kumar Srivastava,et al.  Diffusion tensor imaging and neurocognition in survivors of childhood acute lymphoblastic leukaemia. , 2014, Brain : a journal of neurology.

[26]  Xian-Hong Tong,et al.  The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. , 2013, Human reproduction.

[27]  N. Pavlidis,et al.  Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  A. Pellicer,et al.  Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. , 2013, Fertility and sterility.

[29]  R. Fanchin,et al.  In vitro maturation of oocytes: uncommon indications. , 2013, Fertility and sterility.

[30]  M. Beckmann,et al.  Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval , 2013, Reproductive Biology and Endocrinology.

[31]  Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. , 2019, Fertility and sterility.

[32]  N. Frydman,et al.  Ovarian tissue and follicle transplantation as an option for fertility preservation. , 2012, Fertility and sterility.

[33]  T. Tulandi,et al.  Ovarian reserve and oocyte maturity in women with malignancy undergoing in vitro maturation treatment. , 2011, Fertility and sterility.

[34]  T. Strowitzki,et al.  Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently combined. , 2011, Fertility and sterility.

[35]  Seang Tan,et al.  Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. , 2010, Reproductive biomedicine online.

[36]  P. Rohrlich,et al.  Live birth after ovarian tissue autograft in a patient with sickle cell disease treated by allogeneic bone marrow transplantation. , 2010, Fertility and sterility.

[37]  A. Gougeon Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. , 2010, Annales d'endocrinologie.

[38]  S. Sarnacki,et al.  Preserving Fertility in Prepubertal Children , 2009, Hormone Research in Paediatrics.

[39]  N. Dean,et al.  Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. , 2008, Human reproduction.

[40]  M. Guerquin,et al.  p63 null mutation protects mouse oocytes from radio-induced apoptosis. , 2008, Reproduction.

[41]  A. Byskov,et al.  Morphometric characteristics of the primordial to primary follicle transition in the human ovary in relation to age. , 2007, Human reproduction.

[42]  W. Wallace,et al.  The radiosensitivity of the human oocyte. , 2003, Human reproduction.

[43]  B. Walker,et al.  17beta-estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[44]  I. Yuhanna,et al.  Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. , 1997, Circulation research.

[45]  L. Ignarro,et al.  Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.